Full Text Article Open Access
Citation: Daar Gh, Soni N, Hummler H, Gupta S, More K. Methemoglobinemia: A rare complication of commonly used topical anaesthetic cream. Jr.
med. res. 2025; 7(1):12-14. Daar et al © All rights are reserved. https://doi.org/10.32512/jmr.7.1.2025/12.14
Submit your manuscript:www.jmedicalresearch.com
Case Report
Daar Ghaniya
1*
, Soni Naharmal
1
, Hummler Helmut
1,2
, Gupta Samir
1,3
, More Kiran
1
.
Dr. Samir Gupta1,3, Dr. Kiran More1
Methemoglobinemia: A rare complication of commonly used topical anaesthetic cream.
1: Sidra Medicine, Pediatric Department,
Neonatology Unit, Doha, Qatar.
2: Weill Cornell Medicine, Doha, Qatar.
3: Durham University, United Kingdom.
* Corresponding Author.
Correspondence to:
ghaniyadaar@gmail.com
Publication Data:
Submitted: December 5, 2024
Accepted: March 12,2025
Online: April 30,2025
This article was subject to full peer-
review.
This is an open access article distributed
under the terms of the Creative Commons
Attribution Non-Commercial License 4.0
(CCBY-NC) allowing sharing and adapting.
Share: copy and redistribute the material in
any medium or format.
Adapt: remix, transform, and build upon the
licensed material.
The work provided must be properly cited and
cannot be used for commercial purpose.
Cyanosis is a physical sign stemming from several causes that can develop at any age.
However, its occurrence in the newborn period creates the utmost diagnostic and
treatment challenges due to a very fragile period of the lifespan. Methemoglobinemia
is a condition with life-threatening potential due to diminution of the oxygen-carrying
capacity of circulating hemoglobin. Congenital methemoglobinemia is characterized by
significantly reduced enzymatic activity to transform methemoglobin into functional
hemoglobin. Acquired forms are more commonly seen and usually related to exposure
to certain drugs and agents leading to the increased production of methemoglobin.
We herein report a rare case of acquired methemoglobinemia developed secondary to
the local anesthesia applied for circumcision.
Keywords
Cyanosis; lidocaine; methemoglobinemia; newborn.
Introduction
Methemoglobinemia is a life-threatening hemoglobinopathy related to the oxidation of
divalent ferro-iron of hemoglobin (Hb) to ferri-iron of methemoglobin (MetHb) that
affect oxygen transport. Acquired Methemoglobinemia forms are the most common
and occur due to the exposure to substances that cause oxidation of the Hb directly or
indirectly [1,2].
Observation
A thirteen-day-old male was referred from another facility for circum-oral and
peripheral cyanosis. This was noted by parents six hours after circumcision performed
under local anesthesia: topical anaesthetic cream applied an hour before the
procedure. The patient was born at term, via an uncomplicated vaginal delivery. No
familial history of blood diseases or favism was noted. Weight of 3315g, a length of
51cm and a head circumference of 35.5 cm were recorded. Vital signs were normal.
The patient was pale and dusky with peripheral cyanosis. Cardiac and peripherals
pulses examination was normal. G6PD deficiency and sepsis were ruled out.
Oxygen therapy at 4 L/min was started with mild improvement of the saturation which
variated around 85-88%. Chest X-ray and echocardiography did not reveal any
cyanotic heart disease. Capillary blood gas analysis revealed a methemoglobin level of
46%, lactate 1.6 mmol/L and normal blood electrolyte levels. The diagnosis of
methemoglobinemia was confirmed. Methylene blue of 0.5 mg/kg diluted in Dextrose
5% was given with slow infusion over 10-15 minutes using a filter. The patient
recovered totally and rapidly within 2 hours after the treatment with methylene blue.
All results of capillary blood gas analyses are shown in Table 1.
Abstract
Methemoglobinemia: A rare complication of commonly used topical anaesthetic cream
Citation: Daar Gh, Soni N, Hummler H, Gupta S, More K. Methemoglobinemia: A rare complication of commonly used topical anaesthetic cream. Jr.
med. res. 2025; 7(1):12-14. Daar et al © All rights are reserved. Submit your manuscript: www.jmedicalresearch.com
Before the first dose of
methylene blue
Before the second dose
of methylene blue
One hour after the
second dose
Two hours after the
second dose
7.42
7.43
7.39
7.48
38
33
36
31
33
52
55
42
99.6
94.4
95.3
92.2
1.6
2.1
2.4
1.2
164
141
156
134
4.7
4.9
5.5
4.6
1.38
1.29
1.35
1.41
23.8
23.5
22.6
25.1
0.4
-1.6
-2.7
0.5
46.5
2
2.2
1.6
Table 1. Capillary blood gas analyses evolution under treatment.
Age/ gender
agent
manifestations
Meth-Hb
Treatment
Larson et al.
(2013)
4
months/female
EMLA
®
application over
torso and lower limbs
Seizure
22.8%
Anti-convulsant medication
intravenous methylene blue 1.5
mg/kg
Shachor-Meyouhas
et al. (2008)
28 days/female
EMLA
®
application over
lower back
-
32%
IV MB 0.3 mg/kg
Sinisterra et al.
(2002)
7
months/female
EMLA
®
application over
both groins to cover an
area of ~8 cm
2
-
16%
Double dose of intravenous
methylene blue 2 mg/kg
Couper et al.
(2000)
4 days/ male
EMLA
®
application over
penis
-
16%
-
Elsner et al.
(1997)
7 days/-
EMLA
®
application over
10 cm
2
on sacrum, right
buttocks, upper leg
Sleepiness
-
Kuiper-Prins et al.
(2016)
12 days/ male
EMLA
®
application over
penis
-
16%
Oxygen
Jakobson et al.
(1985)
3 months /male
EMLA
®
application over
back of the hands and in
cubital regions
-
28%
Intravenous methylene blue 1
mg/kg
Bohnhorst et al.
(2017)
1 day/male
Intravenous lidocaine
infusion
Seizure
13.8%
Oxygen
Gala et al. (2017)
26 days/male
Combination of exogenous
(application of silver
sulfadiazine cream over
umbilicus) and
endogenous (sepsis,
diarrhea and acidosis)
Loose motions,
vomiting and
drowsiness
31%
Intravenous methylene blue2 mg/kg
Erol et al (2017)
1 day,male
Maternal prilocain
administration for
pudendal anesthesia
Cyanosis
40%
Double dose of 300 mg/kg of
ascorbic acid
Table 2: methemoglobinemia treatment literature review.
Discussion
We herein report thirteen-day-old neonate with the diagnosis of methemoglobinemia developed after the application of
lidocaine/prilocaine containing local anesthesia for circumcision. The patient completely recovered following the treatment with
intravenous methylene blue. Neonatal methemoglobinemia can be congenital or acquired. Congenital form reveals
progressively with increasing central cyanosis just after birth [3-5]. This form is related to genetic enzymes deficiency and is
rarely responsive to oxygen therapy. However, acquired methemoglobinemia develops secondary to precipitating agents and
may occur at any time in the neonatal period including birth in case of maternal exposure during delivery [6]. The exposure
causes acceleration of Hb oxidization from the ferrous to the ferric state. Several drugs were reported in methemoglobinemia
cases. The most common drugs are benzocaine and lidocaine [7,8]. Newborn infants are particularly susceptible to the
development of methemoglobinemia because the activity of cytochrome b5 reductase (CYB5R) is lower compared to adult. As
MetHb does not transport oxygen, symptoms are essentially respiratory cardiovascular. Both intravenous ascorbic acid and
methylene blue are effective treatments. Methemoglobinemia should always be considered in the differential diagnosis of
cyanosis in newborns and neonates. Prompt diagnosis and treatment are crucial for complete recovery. Local anaesthetic
including lidocaine/prilocaine should be used with caution for routine circumcision.
13
0
Methemoglobinemia: A rare complication of commonly used topical anaesthetic cream
Citation: Daar Gh, Soni N, Hummler H, Gupta S, More K. Methemoglobinemia: A rare complication of commonly used topical anaesthetic cream. Jr.
med. res. 2025; 7(1):12-14. Daar et al © All rights are reserved. Submit your manuscript: www.jmedicalresearch.com
Conflict of Interest: None
References
[1] Iolascon A, Bianchi P, Andolfo I, Russo R, Barcellini W, Fermo E, Toldi G, Ghirardello S, Rees D, Van Wijk R, Kattamis A, Gallagher PG, Roy N, Taher A, Mohty R, Kulozik A, De Franceschi L, Gambale A, De Montalembert M,
Forni GL, Harteveld CL, Prchal J ; SWG of red cell and iron of EHA and EuroBloodNet. Recommendations for diagnosis and treatment of methemoglobinemia. Am J Hematol. 2021 Dec 1 ;96(12) :1666-1678.
[2] Batton R, Villard S, Popoff B. Méthémoglobinémie [Methemoglobinemia]. Rev Med Interne. 2024 Aug;45(8):479-487.
[3] McNulty R, Kuchi N, Xu E, Gunja N. Food-induced methemoglobinemia: A systematic review. J Food Sci. 2022 Apr;87(4):1423-1448.
[4] Gao H, Basri R, Tran MH. Acquired methemoglobinemia: A systematic review of reported cases. Transfus Apher Sci. 2022 Apr;61(2):103299.
[5] Ivek I, Knotek T, Ivičić T, Rubinić B, Bajlo P, Hamzić J. Methemoglobinemia: A Case report and literature review. Acta Clin Croat. 2022 Jun;61(Suppl 1):93-98.
[6] Couper RT. Methaemoglobinaemia secondary to topical lignocaine/ prilocaine in a circumcised neonate. J Paediatr Child Health. 2000 Aug;36(4):406-7.
[7] Larson A, Stidham T, Banerji S, Kaufman J. Seizures and methemoglobinemia in an infant after excessive EMLA application. Pediatr Emerg Care. 2013 Mar;29(3):377-9.
[8] Shachor-Meyouhas Y, Galbraith R, Shavit I. Application of topical analgesia in triage: a potential for harm. J Emerg Med. 2008 Jul;35(1):39-41.
[9] Sinisterra S, Miravet E, Alfonso I, Soliz A, Papazian O. Methemoglobinemia in an infant receiving nitric oxide after the use of eutectic mixture of local anesthetic. J. pediatr.2002;141(2):285-86.
[10] Kuiper-Prins, E., Kerkhof, G.F., Reijnen, C.G.M. et al. A 12-Day-Old Boy with Methemoglobinemia After Circumcision with Local Anesthesia (Lidocaine/Prilocaine). Drug Saf - Case Rep 3, 12 (2016)
[11] Jakobson B, Nilsson A. Methemoglobinemia associated with a prilocaine-lidocaine cream and trimetoprim-sulphamethoxazole. A case report. Acta Anaesthesiol Scand. 1985 May;29(4):453-5.
[12] Gala HC, Madave A. An Unusual Case of Neonatal Methemoglobinemia. Indian Pediatr. 2017 Feb 15;54(2):163.
[13] Erol S, Arslan Z, Han Celik I, Yagmur Bas A, Demire N. Transient Methemoglobinemia in three Neonates due to Maternal Pudendal Anesthesia Journal of the College of Physicians and Surgeons Pakistan 2017, Vol. 27
(12): 783-784.
[14] Rzayev T, Arıcı Ş, Memişoğlu A, Özdemir H, Bilgen H, Özek E. Neonatal methemoglobinemia after subcutaneous injection of Lidocaine to the mother at birth. Turk Arch Pediatr. 2022 Sep;57(5):571-572
14
0